Initial administrative charges to#1 pre-clin TOX study of drug DEV for cancer patients HHSN261201600018I DTP-16-041 TPB

Ended Awarded Jul 1, 2016 Last action Apr 22, 2021

Contract number: HHSN26100001
Awardee: Southern Research Institute UEI CDZJAJJHJMH5
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $724

Award facts

Opportunity: N02CM4700142 Solicitation number

Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
Contract value 100% obligated: $724.00 Current and potential, with all options
Completion date 100% complete: Sep 30, 2016 Current and potential, with all options
NAICS code: 541690 Other Scientific and Technical Consulting Services
PSC: R499 Support- Professional: Other
Set-aside: No set-aside
Competition: Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
Pricing: Firm Fixed Price
Place of performance: Birmingham, AL 35205, USA
Legislative mandates: Service Contract Act FAR subpart 22.10

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Funding Only Action P00002	-$776	Apr 22, 2021
Other Administrative Action 1	$0	Jul 28, 2016
Original award	$1,500	Jul 1, 2016

HHSN26100001 was awarded to Southern Research Institute by National Cancer Institute (National Institutes of Health) on July 1, 2016.

The government has obligated $724 on HHSN26100001.

Yes. HHSN26100001 is a delivery order under HHSN261201600018I, an indefinite delivery contract, on Toxicology of Drugs Developed for Cancer Patients.

The extent of competition for HHSN26100001 was full and open competition. The government received 5 offers.

On GovTribe

Try for free Login